Aetion

During its recent Nexus conference, the Academy of Managed Care Pharmacy (@AMCPorg) discussed the importance of using #RealWorldEvidence (RWE) in health care decisions and set a goal to bring manufacturers and payers together to drive RWE adoption. Read more from the panel session: https://hubs.li/Q02WFNrw0 At Aetion, we’re true believers in the power of RWE, and we’ve developed a suite of applications that put it to work to support critical decisions on safety, effectiveness, and value in the real world. https://hubs.li/Q02WF-hm0

Counting down to #ISPOREurope in Barcelona, Spain! If you plan to be on site, our experts would love to connect at Booth 1212. Also, be sure to catch our research on display across a number of posters, courses, spotlight sessions, breakout sessions, and forums. Book a meeting with us in advance: https://hubs.li/Q02WFNq_0

ICYMI - In the most recent Peek Behind the Paper from The Evidence Base®, Aetion's very own Patrick Arena and Natalie Levy, alongside Gleicy Hair from Merck, discuss their latest publication, which dives into the application of #transportability methods for generating real-world evidence (RWE). Don’t miss this insightful conversation on advancing #RWE generation. Check out the full article here: https://hubs.li/Q02WClYk0 #transportabilitymethods

Accelerate your research with Aetion® Discover. Our intuitive, visual-first application empowers researchers to swiftly extract real-world insights from exploratory studies. Discover combines scientifically validated analytics with pre-built measures and predefined outcomes, allowing you to focus on what matters most—making informed decisions that drive healthcare forward. Stop by Booth 1212 at #ISPOREurope to see for yourself or book a demo with one of our experts in advance: https://hubs.li/Q02WtMS30 #Realworlddata #RWD #Healthcareinnovation

🔬 Curious about the differences between real-world, synthetic, and de-identified data? The latest article from TechTarget dives into these concepts and how they are used to power modern healthcare analytics: https://hubs.li/Q02VVtgL0 At Aetion, we power decision-grade analyses on real-world data using Aetion® Substantiate while maintaining high standards of transparency and audibility. We unlock health data for analysis and HIPAA privacy rule-compliant reuse with Aetion® Generate to de-identify health or create synthetic versions. Our work enables healthcare decision-makers to get access to fit-for-purpose data to drive critical, high-stakes decisions, whether it's for regulatory submissions or payer evaluations. Explore how we turn data into evidence that powers healthcare innovation. #RWE #RWD #HealthcareData #SyntheticData #Deidentification #HIPAAPrivacyRule #HealthTech

No single company or organization can hope to have a meaningful impact on rare disease if they go it alone. As Peter Pitts explored in a recent STAT opinion article, the FDA’s new Rare Disease Innovation Hub can only realize its full potential if participating groups can break down existing silos and work collaboratively. https://hubs.li/Q02VRgPf0 At Aetion, we know the power of bringing together the right data, technology, and partners to make critical healthcare decisions. Read more about our expertise in collaborating with a wide range of regulatory agencies: https://hubs.li/Q02VR6P80

Struggling with data complexity in your healthcare studies? With Aetion® Discover, transform real-world data into actionable insights—faster. Our visual-first, interactive application simplifies complex data, empowering you to generate exploratory insights in real time. Whether you’re exploring treatment patterns or validating research questions, Discover helps you streamline your process, giving you the confidence to make data-driven decisions that matter. Discover the possibilities for yourself at Booth 1212 at #ISPOREurope. Book a demo with us here: https://hubs.li/Q02VJqBw0 #RWD #RWE #DataVisualization

Attending DIA's Real-World Evidence Conference? Join Ulka Campbell, PhD (Head of Scientific Strategy at Aetion), on Thursday, October 24 from 10:30 a.m. - 11:45 a.m. EDT where she will present as part of the session, “Early Development Use Cases.” This session will discuss the application of RWE in early clinical development and in supporting regulatory decision-making. We hope to see you there! Visit our event page: https://hubs.li/Q02Vl-m60

The DIA Real-World Evidence Conference is only a few days away! Be sure to catch our #ATeam of scientists in action throughout the conference programming, as well as on the exhibit floor. Click here to book a meeting with us in advance: https://hubs.li/Q02VkppM0 See you in Philadelphia!

Our president, Kevin Riley, is on the ground at #HLTHUSA in Las Vegas this week, ready to share how Aetion's healthcare solutions - whether it's the advanced analytics of Aetion® Substantiate or the evidence-based AI capabilities of Aetion® Generate - are all rooted in the belief that the biggest innovation we can make is a better decision. Contact us if you'd like to set up a meeting with Kevin onsite: https://hubs.li/Q02V91LC0